Mika Reiner Mayer is one of the most sought-after lawyers in patent prosecution and strategic portfolio management for life sciences startups and established companies alike. Widely known for her strategic insights and deep understanding of business, she is the go-to diligence counsel in Silicon Valley for life science companies and their investors.

Download full bio 


  • Myovant Sciences Acquired by Sumitovant Biopharma 

  • Avidity Biosciences - $289 Million IPO 

  • Vaxcyte - $288 Million IPO 

  • Ciel Medical Acquired by Vyaire Medical 

  • LSP Invests in Vivasure Medical 

  • View all

Mika's prosecution and advice counseling is some of the best I have ever seen. – Peer review, LMG Life Sciences

  • Boston University

  • University of Arizona
    BS, Chemical Engineering

Admissions & Credentials


U.S. Patent and Trademark Office


  • American Bar Association

  • Silicon Valley Intellectual Property Law Association

Rankings & Accolades

    Chambers: Leading Life Sciences and IP Lawyer (Band 1)

    Daily Journal: Named Among Top IP Lawyers, Top Women Lawyers, Top 25 IP Portfolio Managers

    Euromoney Legal Media Group: Best in Patent

    Fellows of the American Bar Foundation: Elected Member

    IAM Patent 1000: Leading Patent Professional

    Legal 500: Leading Lawyer: Patent Prosecution, Healthcare

    LMG Life Sciences: Life Sciences Star, "Patent Strategy Attorney of the Year" (Winner, 2019; Finalist, 2020 - 2022)

    Managing Intellectual Property: Top 250 Women in IP, IP Star

    National Diversity Council: Most Powerful and Influential Women

    The National Law Journal: Intellectual Property Trailblazers 

    The Recorder: Women Leaders in Tech Law

    Silicon Valley Business Journal: Silicon Valley Women of Influence

Cooley Protect

Empowering entrepreneurs and growth companies

Learn more